STAT June 14, 2024
Nicholas St. Fleur

LOS ANGELES – For the past two years, Walgreens has tried to leverage its nationwide footprint to recruit customers who pick up drugs at its stores into clinical trials, in an effort to diversify participation in studies of new medicines.

Other retailers have struggled with similar efforts to expand beyond their core pharmacy operations. Last year, CVS ended its clinical trial endeavors after two years, and earlier this year, Walmart closed several of its medical clinics. Walgreens hasn’t escaped such troubles either, announcing earlier this year it was closing 160 of its Village MD clinics due to slow growth.

Despite this, Walgreens is “doubling down” on its efforts in clinical trials, said Ramita Tandon, the company’s chief clinical trials officer....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Patient / Consumer, Pharma, Pharma / Biotech, Trends
FDA approves clinical trials for pig organ transplants
Supply chains and AI take precedence at European clinical trial meeting
Clinical trial: New drug combination reduces anemia in rare blood disorder
Transforming Clinical Trials with Alexander Saint-Amand
The New Product Development Landscape: Navigating the Challenges

Share This Article